Study period | |||||
---|---|---|---|---|---|
Enrolment | Allocation | Intervention | Post-intervention | ||
Time point/assessment | T0/A0 | T1/A1 | T2/A2 | T3/A3 | |
Study participation | |||||
Eligibility screen | X | ||||
Informed consent | X | ||||
Allocation | X | ||||
Clinical data collection | |||||
Evaluation of adverse events (AE) | X | X | X | X | |
Duration index hospital stay | X | ||||
Duration stays in different wards | X | ||||
Transfer to external hospitals | X | ||||
Transfer to rehabilitation facilities | X | ||||
MPI (geriatric assessment) | X | X | X | X | |
Health literacy | X | X | X | X | |
Quality of life/depression/health status/self-efficacy | X | X | X | X | |
Medication plan | X | X | X | X | |
Minimal Nutritional Assessment | X | X | X | X | |
Mobility tests | X | X | X | X | |
Patient orientation | X | X | X | ||
Personal goals/self-management/personal therapy burden | X | X | X | ||
Photo documentation drugs | X | X | |||
Number of rehospitalizations | X | X | |||
Health economic evaluation | X | ||||
Utilization of rehabilitation services | X | ||||
Length of stay in inpatient facilities | X | ||||
Death | X | ||||
Laboratory data collection | |||||
24-h collection urine | X | X | X | X | |
Clinical chemistry | X | X | X | X |